Wenbin Wu
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
-
- Spine and Intervertebral Disc Pathology 5
- Urology top 10%
-
- IL-33, ST2, and ILC Pathways 4
-
- Pneumonia and Respiratory Infections 4
-
- Asthma and respiratory diseases 4
-
- Nosocomial Infections in ICU 3
-
- Bone Metabolism and Diseases 3
- Extracellular vesicles in disease 2
- Co-authors
- Tiantuo ZhangLimin RongSong Guo ZhengDing-Yun FengFeng HuangXiaoling ZouHailing YangMao Pang
- Journals
- Journal of Hazardous Materials (1 paper)International Journal of Molecular Sciences (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Wenbin Wu
27 papers receiving 528 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 40
- Genetics 78
- Pathology and Forensic Medicine 94
- Urology 33
- Immunology 95
Countries citing papers authored by Wenbin Wu
This map shows the geographic impact of Wenbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Wu more than expected).
Fields of papers citing papers by Wenbin Wu
This network shows the impact of papers produced by Wenbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Wu. The network helps show where Wenbin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2024 | 21 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 3 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 36 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 33 | |
| 12 | 2020 | 20 | |
| 13 | 2020 | 57 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 75 | |
| 17 | 2019 | 29 | |
| 18 | 2017 | 35 | |
| 19 | 2015 | 20 | |
| 20 | 2015 | 20 |
About Wenbin Wu
Wenbin Wu is a scholar working on Molecular Medicine, Endocrinology and Critical Care and Intensive Care Medicine, having authored 27 papers that have together received 535 indexed citations. Recurring topics across this work include Spine and Intervertebral Disc Pathology (5 papers), Pneumonia and Respiratory Infections (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Antibiotic Resistance in Bacteria (4 papers), Asthma and respiratory diseases (4 papers), Nosocomial Infections in ICU (3 papers), Bone Metabolism and Diseases (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Molecular Medicine (40 citations), Genetics (78 citations) and Pathology and Forensic Medicine (94 citations). Wenbin Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Tiantuo Zhang, Limin Rong, Song Guo Zheng, Ding-Yun Feng, Feng Huang, Xiaoling Zou, Hailing Yang, Mao Pang, Junlong Dang and Julie Wang. Their work appears in journals such as Journal of Hazardous Materials, International Journal of Molecular Sciences and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.